Nadege Neant
Overview
Explore the profile of Nadege Neant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ragonnet G, Guilhaumou R, Hanafia O, Neant N, Denante S, Vanel N, et al.
Anaesth Crit Care Pain Med
. 2024 Feb;
43(3):101354.
PMID: 38360404
Context: Beta-lactam continuous infusion (CI) is currently recommended in adult intensive care units to achieve target concentrations. In pediatric intensive care (PICU), few studies suggest the value of Beta-lactam CI...
2.
Ragonnet G, Laroche H, Neant N, Benkouiten S, Dos Santos M, Faucher-Zaegel O, et al.
Br J Clin Pharmacol
. 2024 Jan;
90(3):895-899.
PMID: 38163749
Antiretroviral therapy administration is challenging in patients with HIV requiring enteral nutrition. There are limited pharmacokinetic data available regarding the absorption of crushed rilpivirine (RPV) and its impact on drug...
3.
Neant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, et al.
CPT Pharmacometrics Syst Pharmacol
. 2023 Sep;
12(12):2027-2037.
PMID: 37728045
The role of antiviral treatment in coronavirus disease 2019 hospitalized patients is controversial. To address this question, we analyzed simultaneously nasopharyngeal viral load and the National Early Warning Score 2...
4.
Leblond P, Tresch-Bruneel E, Probst A, Neant N, Solas C, Sterin A, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046681
Preclinical data support the activity of celecoxib and fluvastatin in high-grade (HGG) and low-grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of this combination...
5.
Benaboud S, Solas C, Bouchet S, Gregoire M, Lemaitre F, Venisse N, et al.
J Antimicrob Chemother
. 2023 Jan;
78(3):853-854.
PMID: 36683308
No abstract available.
6.
Lingas G, Neant N, Gaymard A, Belhadi D, Peytavin G, Hites M, et al.
J Antimicrob Chemother
. 2022 Mar;
77(5):1404-1412.
PMID: 35233617
Background: The antiviral efficacy of remdesivir in COVID-19 hospitalized patients remains controversial. Objectives: To estimate the effect of remdesivir in blocking viral replication. Methods: We analysed nasopharyngeal normalized viral loads...
7.
Mehamha H, Doudka N, Minodier P, Neant N, Lacarelle B, Solas C, et al.
Forensic Sci Int
. 2021 Jun;
325:110858.
PMID: 34091410
France is the country with the highest prevalence of cannabis use in Europe, despite the fact that cannabis has not been legalized. This prevalence is still increasing along with THC...
8.
Neant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, et al.
Proc Natl Acad Sci U S A
. 2021 Feb;
118(8).
PMID: 33536313
The characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral kinetics in hospitalized patients and its association with mortality is unknown. We analyzed death and nasopharyngeal viral kinetics in...
9.
Le M, Peiffer-Smadja N, Guedj J, Neant N, Mentre F, Ader F, et al.
J Antimicrob Chemother
. 2020 Oct;
76(1):277-279.
PMID: 33089306
No abstract available.
10.
Le M, Peiffer-Smadja N, Guedj J, Neant N, Mentre F, Ader F, et al.
J Antimicrob Chemother
. 2020 May;
75(9):2376-2380.
PMID: 32473020
Around the world, several dose regimens of hydroxychloroquine have been used for COVID-19 infection treatment, with the objective of identifying a short-term course. Hydroxychloroquine was found to decrease the viral...